The Best Science, the Best People

It’s what we’re invested in.

Why
BioAgilytix?

Because the best science demands the best people.

As a member of BioAgilytix, you will be part of an exciting, expert team supporting new bioanalytical breakthroughs with best-of-breed large molecule services.

Who
You’ll Work With

Meet the members of our global team.

See what they have to say about their BioAgilytix experience.

How
You’ll Benefit

Explore our benefit programs and company perks.

Discover why those are just the start of how a career with BioAgilytix will benefit you both professionally and personally.

What
You’ll Enable

See how your work will change patients’ lives.

Understand all the ways we’re helping our customers achieve more for the patients they serve.

Where to Begin

Submit your resume today!

Explore Our Current Career Openings

BioAgilytixFollow

CRO specializing in large-molecule bioanalysis supporting the development of novel therapeutic biologics and biosimilars. Follow us on Facebook and LinkedIn!

BioAgilytix @BioAgilytix·

Popular #Blog Alert! Cell-based #bioassays are one of the expected release specification methods for #potencyassessments in the drug development process. However, developing these assays under GMP can be challenging, making a strategic approach necessary: http://bit.ly/2FFHVm1

Reply on Twitter 1219615283847081990 Retweet on Twitter 1219615283847081990 Like on Twitter 1219615283847081990 Twitter 1219615283847081990

BioAgilytix @BioAgilytix·

21h

Your next career opportunity is knocking! Learn from team members like Dr. Jay Stringer, Scientist 1, how BioAgilytix’s culture of ‘open doors’ fosters collaboration & professional growth: http://bit.ly/2FJhdJb #BioAgilytixCareers

Reply on Twitter 1219344709853831169 Retweet on Twitter 1219344709853831169 Like on Twitter 1219344709853831169 Twitter 1219344709853831169

BioAgilytix @BioAgilytix·

24h

As the delivery systems used for #genetherapy continue to evolve, #bioanalytical expertise to assess modified, hybrid, and novel vehicles will be more important than ever. Learn why: http://bit.ly/2QGRqaT

Reply on Twitter 1219303933241384961 Retweet on Twitter 1219303933241384961 Like on Twitter 1219303933241384961 Twitter 1219303933241384961

Retweet on Twitter BioAgilytix Retweeted

AstraZeneca@AstraZeneca·

19 Jan

#Ovariancancer is the 8th most common #cancer in women, affecting approximately 300,000 women worldwide in 2018. Understanding its many risk factors is important, especially as these can impact prognosis.

Reply on Twitter 1218882810825494528 Retweet on Twitter 121888281082549452810 Like on Twitter 12188828108254945289 Twitter 1218882810825494528

BioAgilytix @BioAgilytix·

19 Jan

#Vegas ... you were amazing! #AnnualBDMeeting #workhardplayhard #backtoNC

Reply on Twitter 1218991988323733505 Retweet on Twitter 1218991988323733505 Like on Twitter 1218991988323733505 Twitter 1218991988323733505

BioAgilytix

4 days ago

If you're in the Bay area on January 22, we want to see you! BioAgilytix’s Dr. Lydia Michaut will be hosting a workshop on “Bioanalysis for Cell & Gene Therapies”. More info here: lnkd.in/ecPtUDA ... See MoreSee Less

Photo

View on Facebook

BioAgilytix

1 week ago

It's not too late to register for next week's webinar!! ... See MoreSee Less

Photo

View on Facebook

BioAgilytix updated their cover photo.

2 weeks ago

BioAgilytix's cover photo ... See MoreSee Less

Photo

View on Facebook